# Lisdexamfetamine Dimesylate

NDC: 0378-6855
Generic name: lisdexamfetamine
Labeler / Manufacturer: Mylan Pharmaceuticals Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20230825

FDA application: ANDA202835

## Active ingredients

- LISDEXAMFETAMINE DIMESYLATE: 20 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0378-6855"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0378-6855
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=efbde0f6-b848-4664-b741-c6c630e66108